99 related articles for article (PubMed ID: 6490799)
21. Postmenopausal hot flushes: a disorder of thermoregulation.
Tataryn IV; Lomax P; Bajorek JG; Chesarek W; Meldrum DR; Judd HL
Maturitas; 1980 Jul; 2(2):101-7. PubMed ID: 7207212
[TBL] [Abstract][Full Text] [Related]
22. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous telemetric monitoring of tail-skin and core body temperature in a rat model of thermoregulatory dysfunction.
Cosmi S; Pawlyk AC; Alfinito PD; Roman J; Zhou T; Deecher DC
J Neurosci Methods; 2009 Apr; 178(2):270-5. PubMed ID: 19135085
[TBL] [Abstract][Full Text] [Related]
24. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
[TBL] [Abstract][Full Text] [Related]
25. Objectively recorded hot flushes in patients with pituitary insufficiency.
Meldrum DR; Erlik Y; Lu JK; Judd HL
J Clin Endocrinol Metab; 1981 Apr; 52(4):684-8. PubMed ID: 6782116
[TBL] [Abstract][Full Text] [Related]
26. Effect of clonidine on hot flashes in postmenopausal women.
Laufer LR; Erlik Y; Meldrum DR; Judd HL
Obstet Gynecol; 1982 Nov; 60(5):583-6. PubMed ID: 7145250
[TBL] [Abstract][Full Text] [Related]
27. New steroid for the climacteric syndrome.
Kicovic PM
Minerva Endocrinol; 1989; 14(1):63-7. PubMed ID: 2659954
[TBL] [Abstract][Full Text] [Related]
28. Effect of estrogen on the growth hormone response to the alpha-adrenergic agonist clonidine in women with menopausal flushing.
Tulandi T; Lal S; Guyda H
J Clin Endocrinol Metab; 1987 Jul; 65(1):6-10. PubMed ID: 2884230
[TBL] [Abstract][Full Text] [Related]
29. Estrogenic control of thermoregulation in ERalphaKO and ERbetaKO mice.
Opas EE; Gentile MA; Kimmel DB; Rodan GA; Schmidt A
Maturitas; 2006 Jan; 53(2):210-6. PubMed ID: 15908148
[TBL] [Abstract][Full Text] [Related]
30. ICI 182,780 penetrates brain and hypothalamic tissue and has functional effects in the brain after systemic dosing.
Alfinito PD; Chen X; Atherton J; Cosmi S; Deecher DC
Endocrinology; 2008 Oct; 149(10):5219-26. PubMed ID: 18599545
[TBL] [Abstract][Full Text] [Related]
31. [Changes of plasma serotonin precursor metabolite concentrations in postmenopausal women with hot flushes].
Chen Y; Lü X; Huang Y; Xin X; Ye X
Zhonghua Fu Chan Ke Za Zhi; 2002 Dec; 37(12):726-8. PubMed ID: 12622915
[TBL] [Abstract][Full Text] [Related]
32. The menopausal hot flush: symptom reports and concomitant physiological changes.
Swartzman LC; Edelberg R; Kemmann E
J Behav Med; 1990 Feb; 13(1):15-30. PubMed ID: 2348448
[TBL] [Abstract][Full Text] [Related]
33. The effects of naloxone on hot flashes and gonadotropin secretion in postmenopausal women.
DeFazio J; Verheugen C; Chetkowski R; Nass T; Judd HL; Meldrum DR
J Clin Endocrinol Metab; 1984 Mar; 58(3):578-81. PubMed ID: 6420445
[TBL] [Abstract][Full Text] [Related]
34. Hot flushes: mechanism and prevention.
Radlmaier A; Bormacher K; Neumann F
Prog Clin Biol Res; 1990; 359():131-40; discussion 141-53. PubMed ID: 2149457
[No Abstract] [Full Text] [Related]
35. The pathophysiology of postmenopausal hot flushes.
Lomax P
Reproduccion; 1982; 6(2):93-9. PubMed ID: 6292025
[No Abstract] [Full Text] [Related]
36. Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats.
Ederveen AG; Kloosterboer HJ
J Bone Miner Res; 1999 Nov; 14(11):1963-70. PubMed ID: 10571697
[TBL] [Abstract][Full Text] [Related]
37. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
Landgren MB; Helmond FA; Engelen S
Maturitas; 2005 Mar; 50(3):222-30. PubMed ID: 15734603
[TBL] [Abstract][Full Text] [Related]
38. Physiological aspects of menopausal hot flush.
Sturdee DW; Wilson KA; Pipili E; Crocker AD
Br Med J; 1978 Jul; 2(6130):79-80. PubMed ID: 667570
[TBL] [Abstract][Full Text] [Related]
39. A double blind cross-over study on the effects of ORG OD14 compared to estradiol valerate and placebo on the fatty acid composition of serum lecithin and cholesterol ester in oophorectomized women.
Crona N; Silfverstolpe G; Samsioe G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1116-9. PubMed ID: 6841554
[TBL] [Abstract][Full Text] [Related]
40. The need for tissue selective menopausal agents.
Eden J
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
